DRREDDY: Looks Good in Weekly, Witnessing Strong Reversal.
Possibility of Point "C" Completed as to form Bearish SHARK.
as C = FIB R 1.625 of XA, IDEAL is FIB R 1.618
Go LONG @ 2160 (LTP at 12.58 pm)
TARGET (Intraday): @ 2184, @ 2191, @ 2214, @ 2221, @ 2231 - @ 2240(HZ), @ 2261+
TARGET (Positional): @ 2279, @ 2347, @ 2385, @ 2409, @ 2447 - @ 2475 (HZ), @ 2548+
More Short to Medium Term plotted on Chart.
More Accumulate: @ 2142 - @ 2130
More Updates Later (including DAILY CHART)
Strategy for OPTION:
LONG 2150CE @ 80.05 + SHORT 2300CE: @ 28.30
RISK: @ 10440/+, Reward: 19560/=
RISK REWARD RATIO: Below 0.6
For more: On Query.
Disclaimer: Only For STUDY. For Taking Trade Decision Consult Financial Advisor.
LIKE / Comment /Share, If useful & enriched your knowledge.
With Warm Regards.
DSKF16.
Possibility of Point "C" Completed as to form Bearish SHARK.
as C = FIB R 1.625 of XA, IDEAL is FIB R 1.618
Go LONG @ 2160 (LTP at 12.58 pm)
TARGET (Intraday): @ 2184, @ 2191, @ 2214, @ 2221, @ 2231 - @ 2240(HZ), @ 2261+
TARGET (Positional): @ 2279, @ 2347, @ 2385, @ 2409, @ 2447 - @ 2475 (HZ), @ 2548+
More Short to Medium Term plotted on Chart.
More Accumulate: @ 2142 - @ 2130
More Updates Later (including DAILY CHART)
Strategy for OPTION:
LONG 2150CE @ 80.05 + SHORT 2300CE: @ 28.30
RISK: @ 10440/+, Reward: 19560/=
RISK REWARD RATIO: Below 0.6
For more: On Query.
Disclaimer: Only For STUDY. For Taking Trade Decision Consult Financial Advisor.
LIKE / Comment /Share, If useful & enriched your knowledge.
With Warm Regards.
DSKF16.
Trade active
LTP: @ 2130 (at 1.57 pm)Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.